Virtual Meeting Program
Throughout the next few months, SOT will be presenting Scientific Sessions and Continuing Education courses originally planned for presentation in Anaheim as live webinars. This web page will be updated regularly as webinars are confirmed and registration details become available.
Thank You Diamond Supporters
Virtual Meeting Schedule
Last updated 6/5/2020More than 600 ePosters are available for viewing through the online version of the app, as well as the Online Planner and SOT Event App. SOT also has developed a 2020 ePoster Index , allowing you to view the ePosters by Poster Session.
Tuesday, June 9
1:00 PM to 2:30 PM (ET)
A CURE for the Common Classroom: Engaging Students and Faculty in Course-Based Undergraduate Research Experiences to Maximize Academic Success and Productivity
Chairs: Larissa Williams, Bates College; and Joshua Gray, US Coast Guard Academy.
Primary Endorser: Faculty United for Toxicology Undergraduate Recruitment and Education (FUTURE) Committee
Other Endorsers: Committee on Diversity Initiatives (CDI); Hispanic Organization of Toxicologists Special Interest Group
Thursday, June 11
12:00 Noon to 2:45 PM (ET)
Sex, Lungs, and Air Pollution
Chairs: Meghan E. Rebuli, University of North Carolina at Chapel Hill; and Robert M. Tighe, Duke University.
Primary Endorser: Inhalation and Respiratory Specialty Section
Other Endorsers: Clinical and Translational Toxicology Specialty Section; Women in Toxicology Special Interest Group
Tuesday, June 16
12:00 Noon to 2:45 PM (ET)
New Data and Tools for Understanding Chemical Distribution In Vitro
Chairs: Nynke Kramer, Universiteit Utrecht; and John Wambaugh, US EPA.
Primary Endorser: Biological Modeling Specialty Section
Thursday, June 18
1:00 PM to 3:45 PM (ET)
Toxicological Exposure and Risk Assessment of Emissions from 3D Printers
Chairs: Trey Thomas, US Consumer Product Safety Commission; and Yong Qian, NIOSH.
Primary Endorser: Nanoscience and Advanced Materials Specialty Section
Friday, June 19
12:00 Noon to 3:30 PM (ET)
CONTINUING EDUCATION COURSE PM09: AAV Vectors on the Move: Safety Assessment and Advancing Sciences in Gene Therapy Second-Generation Products
Chairs: Sven Korte, Covance Preclinical Services GmbH, Germany; and Annette Koerner, F. Hoffmann-La Roche Ltd, Switzerland.
Primary Endorser: Regulatory and Safety Evaluation Specialty Section
Other Endorsers: Biotechnology Specialty Section
Note: Continuing Education (CE) courses require a paid registration. Those who registered to attend the CE course in Anaheim are registered for the course. If you were not previously registered, you may register to attend.
Thursday, June 25
1:00 PM to 2:30 PM (ET)
Individual-, Community-, and Population-Level Environmental-Associated Attributes of Disparate Health Outcomes in Vulnerable Populations
Chairs: Darryl Hood, Ohio State University; and Paul Juarez, Meharry Medical College.
Primary Endorser: Toxicologists of African Origin Special Interest Group
Other Endorsers: Education and Career Development Committee; Graduate Student Leadership Committee
6:00 PM to 8:45 PM (ET)
Can We Predict and Manage Immune-Related Adverse Events Associated with Cancer Immunotherapy?
Chairs: Yasuo Yoshioka, Osaka University; and Peyton Myers, US FDA/CDER.
Primary Endorser: Immunotoxicology Specialty Section
Friday, June 26
12:00 Noon to 3:30 PM (ET)
CONTINUING EDUCATION COURSE AM05: Lung Function: It's Not Just Breathing
Chairs: Andrew Gow, Rutgers, The State University of New Jersey; and Angela Groves, University of Rochester Medical Center.
Primary Endorser: Inhalation and Respiratory Specialty Sectionn
Other Endorsers: Comparative Toxicology, Pathology, and Veterinary Specialty Section; Computational Toxicology Specialty Section
Note: Continuing Education (CE) courses require a paid registration. Those who registered to attend the CE course in Anaheim are registered for the course. If you were not previously registered, you may register to attend.
Tuesday, June 30
12:00 Noon to 2:45 PM (ET)
Immune-Mediated Adverse Drug Reactions: State-of-the-Art Learnings from Preclinical and Clinical Drug Development
Chairs: Amy Sharma, Genentech Inc.; and James Monroe, Merck & Co. Inc.
Primary Endorser: Immunotoxicology Specialty Section
Other Endorser: Biotechnology Specialty Section